TrialSpark

Company

Investment-firm

Last deal

$372M

Amount

Series D

Stage

26.06.2024

Date

4

all rounds

$528M

Total amount

General

About Company
TrialSpark is a technology company that helps bring treatments to patients faster by reimagining how clinical trials are run.

Industry

Sector :

Subsector :

founded date

01.06.2014

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

The company has developed a platform that optimizes all aspects of a clinical trial, from trial design to data quality, and has scaled a network of trial sites by partnering with doctors to create clinical trial sites within their existing practices using a roaming cohort of certified research coordinators, optimized by software, data, and technology. TrialSpark also in-licenses and co-develops drug programs through in-house development, joint ventures, and NewCos, with the goal of using technology to accelerate the pace of clinical trials and bridge the gap between medical research and patients who need treatment.
Contacts